Search results
Results from the WOW.Com Content Network
McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...
BOSTON (Reuters) -McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker ...
Oxycodone/paracetamol, sold under the brand name Percocet among others, is a fixed-dose combination of the opioid oxycodone with paracetamol (acetaminophen), used to treat moderate to severe pain. [1] In 2022, it was the 98th most commonly prescribed medication in the United States, with more than 6 million prescriptions. [2] [3]
The Drug Enforcement Administration (DEA) lists oxycodone both for sale and for use in manufacturing other opioids as ACSCN 9143 and in 2013 approved the following annual aggregate manufacturing quotas: 131.5 metric tons for sale, down from 153.75 in 2012, and 10.25 metric tons for conversion, unchanged from the previous year. [172]
Oxycodone/aspirin (trade name Percodan) is a combination drug marketed by Endo Pharmaceuticals. It is a tablet containing a mixture of 325 mg (5 grains ) of aspirin and 4.8355 mg of oxycodone HCl (equivalent to 4.3346 mg of oxycodone as the free base); it is an opioid/non-opioid combination used to treat moderate to moderately severe pain. [ 1 ]
The opioid crisis took root in the 1990s. In 1995, the FDA approved Purdue Pharma's application for a new drug called OxyContin. At the time, the medical community as a whole was rethinking its ...
Sackler was certified by the American Board of Psychiatry and Neurology (P) in 1957, and was a Life Fellow of the American Psychiatric Association. [10] Sackler, with his two brothers, Arthur and Mortimer, co-founded the Creedmoor Institute for Psychobiological Studies in New York City, where they engaged in research in the psycho-biology of schizophrenia and manic depressive psychosis.
Members of the wealthy Sackler family, owners of OxyContin maker Purdue Pharma LP, have long denied that the $10 billion they transferred from their company over the course of a decade was an ...